. Author manuscript; available in PMC: 2019 Jun 24.

Published in final edited form as: J Hepatol. 2017 Mar 4;67(1):32–39. doi: 10.1016/j.jhep.2017.02.027

Table 3.

Association between HCC and SVR in multivariable logistic regression models.

	All patients (n = 15,573)		Genotype 1 (n = 12,493)		Genotype 2 (n = 1,868)		Genotype 3 (n = 1,084)

	AOR (95% CI)^†	p value	AOR (95% CI)^†	p value	AOR (95% CI)^†	p value	AOR (95% CI)^†	p value

No HCC	1	-	1	-	1	-	1	-
HCC	0.38 (0.29, 0.48)	<0.001	0.34 (0.26, 0.45)	<0.001	0.59 (0.25,1.38)	0.224	0.41 (0.22, 0.76)	0.005
HCC/LT	1.57 (0.75,3.28)	0.23	1.89 (0.68,5.20)	0.21	0.10(0.01, 0.82)	0.03	2.7 (0.58, 12.6)	0.20

^†

AOR: Adjusted odds ratio, by multivariable logistic regression modeling including age, gender, race/ethnicity, alcohol use disorders, genotype, subgenotype, HCV regimen, baseline HCV viral load, diabetes, treatment naive/experienced, cirrhosis, decompensated cirrhosis, platelet count, bilirubin, and albumin. HCC, hepatocellular carcinoma; HCC/LT, HCC with previous liver transplantation.